Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2025 > Vol 6, №6 (2025) > Intrahepatic cholangocarcinoma in a comorbid patient: is a rare diagnosis – a difficult diagnostic search. Clinical example and review literature

Intrahepatic cholangocarcinoma in a comorbid patient: is a rare diagnosis – a difficult diagnostic search. Clinical example and review literature

Vitaly V. Gorban , Elena N. Travenko , Valery A. Porodenko

For citation:


  • Abstract
  • About the Author
  • References

Abstract

The relevance of the work is due to the need to increase oncological alertness among primary health care doctors in relation to comorbid patients due to the increase in the prevalence of hepatocellular carcinoma, metastatic liver lesions, cholangiocellular cancer, as well as their late detection and difficulties diagnostics due to the absence of not only pathognomonic, but also relatively specific laboratory and instrumental signs. The article describes the stages of a difficult diagnostic search in a comorbid patient with intrahepatic cholangiocarcinoma, which led to a fatal outcome, which served as the basis for relatives to file a claim for compensation for moral harm, since the diagnosis of the oncoprocess, in their opinion, could be established at the polyclinical stage of observation. Purpose of the clinical case intrahepatic cholangiocarcinoma is the accumulation of actual material for early differentiated hepatobiliary oncological diagnosis. 
Keywords: intrahepatic cholangiocarcinoma, hepatocellular carcinoma, diagnosis, markers of cancer.

About the Author

Vitaly V. Gorban 1 , Elena N. Travenko 1 , Valery A. Porodenko 1

1 Kuban State Medical University, Krasnodar, Russia

References

1. Choi JH, Thung SN. Recent Advances in Pathology of Intrahepatic Cholangiocarcinoma. Cancers 2024;16:1537. DOI: 10.3390/cancers16081537 
2. American Cancer Society. Key Statistics for Bile Duct Cancer. 2024. URL: https://www.cancer.org/cancer/bile-duct-cancer/about/key-statistics.html 
3. Omouri-Kharashtomi M, Alemohammad SY, Moazed N et al. Prognostic value of albumin‐bilirubin BMC Gastroenterology grade in patients with cholangiocarcinoma: a systematic review and meta‐analysis. BMC Gastroenterology 2025;25:19. DOI: 10.1186/s12876‐025‐03596‐6 
4. Brindley PJ, Bachini M, Ilyas SI et al. Cholangiocarcinoma. Nat Rev Dis Primers 2022;7(1):65. DOI: 10.1038/s41572-021-00300-2 
5. Colangelo M, Martino MD, Polidoro MA et al. Management of intrahepatic cholangiocarcinoma: a review for clinicians. Gastroenterology Report 2025;13:goaf005 DOI: 10.1093/gastro/goaf005 
6. Лукьянченко А.Б., Медведева Б.М., Шабанов М.А. и др. Внутрипеченочная холангиокарцинома. Вестник рентгенологии и радиологии. 2015;(1):52-63. DOI: 10.20862/0042-4676-2015-0-1-52-63 Luk’yanchenko A.B., Medvedeva B.M., Shabanov M.A. et al. Intrahepatic cholangiocarcinoma. Journal of radiology and nuclear medicine. 2015;(1):52-63. DOI: 10.20862/0042-4676-2015-0-1-52-63 (in Russian). 
7. Komuta M. Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance. Clinical and Molecular Hepatology 2022;28:396-407. DOI: 10.3350/cmh.2021.0287 
8. Sun D, XU Z, Cao S et al. Imaging features based on CT and MRI for predicting prognosis of patients with intrahepatic cholangiocarcinoma: a single-center study and meta-analysis. Cancer Imaging 2023;23(56). DOI: 10.1186/s40644-023-00576-5 
9. Ищенко Р.В., Андреева М.А., Яковлева Е.В., Ищенко К.Б. Иммуногистохимический анализ первичного рака печени. Злокачественные опухоли. 2016;(19):44-52. DOI: 10.18027/2224–5057–2016–2–Х–Х Ischenko R.V., Andreeva M.A., Yakovleva E.V., Ishchenko K.B. I Immunohistochemical analysis of primary liver cancer. Malignant Tumours 2016;(2):44-52. DOI: 10.18027/2224–5057–2016–2–44–52 (in Russian). 
10. Khosla D, Misra S, Chu PL et al. Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic Approaches. Cancers 2024;16:801. DOI: 10.3390/cancers16040801 
11. Calderaro J, Seraphin TP, Luedde T, Simon T.G. Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma. Hepatol 2022;76(6):1348-61. DOI: 10.1016/j.jhep.2022.01.014 
12. Coffin P., He A. Hepatocellular Carcinoma: Past and Present Challenges and Progress in Molecular Classification and Precision Oncology. Int J Mol Sci 2023;24:13274. DOI: 10.3390/ijms241713274 
13. Wang Z, Qin H, Liu S et al. Precision diagnosis of hepatocellular carcinoma. Chinese Medical Journal 2023;136(10). DOI: 10.1097/CM9.0000000000002641 
14. de Mattos AZ, Bombassaro IZ, Vogel A, Debes JD. Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice. World J Gastroenterol 2024;30(19):2488-95. DOI: 10.3748/wjg.v30.i19.2488 
15. Кириенко В.Т., Зайцев И.А., Грушкевич В.В., Потий В.В. Скрининг и ранняя диагностика гепатоцеллюлярной карциномы. Актуальная инфектология. 2018;6(2):70-6. DOI: 10.22141/2312-413x.6.2.2018.131091 Kiriienko V.T., Zaitsev I.A., Hrushkevych V.V., Potii V.V. Screening and early diagnosis of hepatocellular carcinoma. Current infectology. 2018;6(2):70-6. DOI: 10.22141/2312-413x.6.2.2018.131091 (in Russian). 
16. Катрич А.Н., Рябин Н.С., Польшиков С.В., Катрич Н.А. Ультразвуковое исследование с контрастным усилением в дифференциальной диагностике фокально-нодулярной гиперплазии и гепатоцеллюлярной аденомы печени. Кубанский научный медицинский вестник. 2019;26(2):50-63. DOI: 10.25207/1608-6228-2019-26-2-50-63 Katrich A.N., Ryabinin N.S., Polshikov S.V., Katrich N.A. Contrast-enchanced ultrasound in the differential diagnosis of focal nodular hyperplasia and hepatic adenoma. Kuban Scientific Medical Bulletin. 2019;26(2):50-63. DOI: 10.25207/1608-6228-2019-26-2-50-63 (in Russian). 
17. Петкау В.В., Бессонова Е.Н., Бредер В.В., Анашкина М.А. Первые результаты скрининга гепатоцеллюлярного рака в группе риска. Доказательная гастроэнтерология. 2023;12(4):54-9. DOI.10.17116/dokgastro20231204154 Petkau V.V., Bessonova E.N., Breder V.V., Anashkina M.A. Preliminary findings of hepatocellular carcinoma screening in the at-risk population. Russian Journal of evidence-based Gastroenterology 2023;12(4):54-9. DOI: 10.17116/dokgastro20231204154 (in Russian). 
18. Piñero F, Dirchwolf M, Pessôa MG. Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment. Cells 2020;9:1370. DOI: 10.3390/cells9061370 
19. Renne SL, Sarcognato S, Sacchi D et al. Hepatocellular carcinoma: a clinical and pathological overview. Pathologica 2021;113:203-17. DOI: 10.32074/1591-951X-295 
20. Velardi GG, Lico M, Teti A et al. Diagnosis of intrahepatic cholangiocarcinoma with CEUS. J Ultrason 2024;24:5. DOI: 10.15557/JoU.2024.0005 
21. Moris D, Palta M, Kim C et al. Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians. CA: A cancer journal for clinicans 2023;73(2):198-222. DOI: 10.3322/caac.21759 
22. Petrick JL, Yang B, Аltekruse S et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma Medicare. Plos One 2017;12:0186643. DOI: 10.1371/journal.pone.0186643 
23. Labib PL, Goodchild G. and Pereira S.P. Molecular Pathogenesis of Cholangiocarcinoma. BMC Cancer 2019;19:185. DOI: 10.1186/s12885-019-5391-0 
24. Cai H, Kong Wen-Tao, Chen Chao-Boб et al. Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: a meta-analysis of observational studies. BMC Cancer 2015;15:831. DOI: 10.1186/s12885-015-1870-0 
25. Сутягин А.А., Щелоченков С.В., Щелоченкова Т.Д. и др. Внутрипеченочная холангиокарцинома на фоне множественного холангиолитиаза как плохо диагностируемая проблема в клинической практике. Эффективная фармакотерапия. 2021;17(39):88-93. DOI 10.33978/2307-3586-2021-17-39-88-93 Sutyagin A.A., Shchelochenkov S.V., Shchelochenkova T.D. et al. Intrahepatic Cholangiocarcinoma on the Background of Multiple Cholangiolithiasis as a Poorly Diagnosed Problem in Clinical Practice. Effective pharmacotherapy 2021;17(39):88-93. DOI 10.33978/2307-3586-2021-17-39-88-9 (in Russian). 
26. Kim HJ, Kim JS, Joo MK et al. Hepatolithiasis and intrahepatic cholangiocarcinoma: a review. World J. Gastroenterol 2015;21(48):13418-31. DOI: 10.3748/wjg.v21.i48.13418 
27. Kam AE, Masood A, Shroff RT. Current and emerging therapies for advanced biliary tract cancers. Lancet Gastroenterol Hepatol 2021;6(11):956-69. DOI: 10.1016/S2468-1253(21)00171-0. PMID: 34626563 
28. Гришечкина И.А., Гасаненко Л.Н., Кондратьева Н.А. и др. Бессимптомное течение внутрипеченочной холангиокарциномы. Клинические наблюдения. Экспериментальная и клиническая гастроэнтерология. 2016;131(7):135-7. Grishechkina I.A., Gasanenko L.N., Kondrateva N.A. et al. Asymptomatic intrahepatic cholangiocarcinoma.Clinical case. Experimental and clinical gastroenterology 2016;131(7):135-8 (in Russian). 
29. Бредер В.В., Алиханов Р.Б., Багненко С.С. и др. Скрининг и ранняя диагностика гепатоцеллюлярного рака и оптимизация методов диагностической визуализации: обзор литературы и заключение совета экспертов. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2022;32(5):16-23. DOI: 10.22416/1382-4376-2022-32-5-16-23 Breder V.V., Alikhanov R.B., Bagnenko S.S. et al. Screening and Early Diagnosis of Hepatocellular Cancer and Optimization of Diagnostic Imaging Techniques: A Review and Conclusion of the Expert Panel. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2022;32(5):16-23. DOI: 10.22416/1382-4376-2022-32-5-16-23 (in Russian). 
30. Воробьева О.В. Редкий случай холангиоцеллюлярного рака печени с гематогенными метастазами и изменения в органах при генерализации процесса. Креативная хирургия и онкология. 2022;12(3):244-9. DOI.10.24060/2076-3093-2022-12-3-244-249 Vorobeva O.V. A Rare Case of Cholangiocellular Liver Cancer with Hematogenous Metastases and Organ Changes in the Generalization of the Process. Creative surgery and oncology. 2022;12(3):244-9. DOI: 10.24060/2076-3093-2022-12-3-244-249 (in Russian). 
31. Фурсова Л.А, Лихачева Е.М. Паранеопластические спинальные синдромы (научный обзор и личное наблюдение). Международный неврологический журнал. 2017;4(90):69-76. DOI: 10.22141/2224-0713.4.90.2017.107265 Fursova L.A., Lihachova E.M. Paraneoplastic spinal cord syndromes (literature review and personal observation). International Neurological Journal. 2017;4(90):69–76. DOI: 10.22141/2224-0713.4.90.2017.107265 (in Russian). 
32. Ghouri YA, Mian I, Blechacz B. Cancer review: Cholangiocarcinoma. J Carcinog 2015;14 (1). DOI: 10.4103/1477-3163.151940 
33. Macias RIR, Cardinale V, Kendall TJ et al. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions. Gut 2022;71(8):1669-83. DOI: 10.1136/gutjnl-2022-327099 
34. Kakar S, Muir T, Murphy LM et al. Immunoreactivity of Hep Par 1 in Hepatic and Extrahepatic Tumors and Its Correlation With Albumin In Situ Hybridization in Hepatocellular Carcinoma. American Journal of Clinical Pathology 2003;119(3):361-6. DOI: 10.1309/8L872RPHEJRKF5JJ 
35. Fan Z, van de Rijn M, Montgomery K, Rouse RV. Hep Par 1 Antibody Stain for the Differential Diagnosis of Hepatocellular Carcinoma: 676 Tumors Tested Using Tissue Microarrays and Conventional Tissue Sections. Mod Pathol 2003;16(2):137-44. DOI: 10.1097/01.MP.0000052103.13730.20 
36. Leong AS, Sormunen RT, Tsui WM, Liew CT. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology 1998;33(4):318-24. DOI: 10.1046/j.1365-2559.1998.00522.x 
37. Гурмиков Б.Н., Калинин Д.В., Никитин И.Г. и др. Частота и влияние мутации гена KRASна выживаемость больных после хирургического лечения внутрипеченочного холангиоцеллюлярного рака. Кубанский научный медицинский вестник. 2020;27(2):59-65. DOI: 10.2527/1608-6228-2020-27-2-59-65 Gurmikov B.N., Kalinin D.V., Nikitin I.G. et al. Frequency and impact of KRAS gene mutation on survival of patients after surgical treatment of intrahepatic cholangiocellular carcinoma. Kuban Scientific Medical Bulletin. 2020;27(2):59-65. DOI: 10.2527/1608-6228-2020-27-2-59-65 (in Russian).

For citation: Gorban V.V., Travenko E.N., Porodenko V.A. Intrahepatic cholangocarcinoma in a comorbid patient: is a rare diagnosis – a difficult diagnostic search. Clinical example and review literature. Clinical review for general practice. 2025; 6 (6): 47–53 (In Russ.). DOI: 10.47407/kr2025.6.6.00629


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

Scopus
doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru